Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Cash & Equivalents (2016 - 2026)

Glaukos has reported Cash & Equivalents over the past 14 years, most recently at $104.2 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 8.76% to $104.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $104.2 million through Mar 2026, down 8.76% year-over-year, with the annual reading at $90.8 million for FY2025, 46.46% down from the prior year.
  • Cash & Equivalents was $104.2 million for Q1 2026 at Glaukos, up from $90.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $169.6 million in Q4 2024 and troughed at $42.5 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $100.8 million (2025), against an average of $99.7 million.
  • The largest YoY upside for Cash & Equivalents was 168.86% in 2025 against a maximum downside of 46.46% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $119.5 million in 2022, then dropped by 21.8% to $93.5 million in 2023, then skyrocketed by 81.48% to $169.6 million in 2024, then plummeted by 46.46% to $90.8 million in 2025, then increased by 14.8% to $104.2 million in 2026.
  • Per Business Quant, the three most recent readings for GKOS's Cash & Equivalents are $104.2 million (Q1 2026), $90.8 million (Q4 2025), and $98.2 million (Q3 2025).